| Name | Title | Contact Details |
|---|
Cedars-Sinai is a non-profit, academic, community-centric, Level 1 Trauma Center in Los Angeles, California. Recognized internationally, Cedars-Sinai brings together top healthcare professionals collaborating to provide exceptional patient care. A combination of patient satisfaction scores, clinical performance initiatives, excellent medical outcomes, national designations and awards and ongoing research and academic programs have earned Cedars-Sinai a top spot on the Honor Roll in the 2014-15 issue of America`s Best Hospitals by U.S. News and World Report. Out of nearly 5,000 hospitals surveyed for the annual rankings, Cedars-Sinai is among just 17 hospitals nationwide to earn the magazine’s Honor Roll designation. To be named to the Honor Roll, a hospital must be rated among the nation’s top 50 programs in at least six specialties. Cedars-Sinai was ranked in 12 categories, including: Cancer; Cardiology and Heart Surgery; Diabetes and Endocrinology; Ear, Nose and Throat; Gastroenterology and GI Surgery; Geriatrics; Gynecology; Nephrology, Neurology and Neurosurgery; Orthopedics; Pulmonology; and Urology. Cedars-Sinai has also received its fourth consecutive Magnet® recognition for nursing excellence from the American Nurses Credentialing Center (ANCC), becoming the hospital with the longest-running Magnet designation in California. Nationwide, only about 5% of hospitals have earned the four-year Magnet designation. Cedars-Sinai was the first Southern California hospital to earn the Magnet honor in 2000, and one of only six hospitals to receive this designation three times. Studies show that Magnet hospitals tend to have lower mortality and infection rates, as well as higher patient satisfaction and nurse staffing levels.
Absolute Awakenings is a New Jersey-based drug and alcohol addiction treatment center that offers long-term recovery solutions for those struggling with addiction and alcoholism.
FinPay, LLC provides Patient Financial Management Solutions to assist healthcare providers in their strategy to manage the $400 billion in patient out-of-pocket medical expenses that has caused a massive spike in bad debt and lost revenue to providers nationwide. The continuing shift of financial responsibility to the patient for the cost of healthcare has forced healthcare providers to rethink their Patient Financial Management strategy. FinPay`s solution provides: 1. Financial Clearance Policies that target and segment patients that pose a high financial risk to the provider and customized work flow for these high risk patients. 2. Patient engagement at the point of care to educate patients about their financial obligations and to manage patient expectations on the billing and claims process. 3. An automated payments platform that offers patients more alternatives for payment. Our platform automates patient installment plans and consumer non-recourse medical loans, in addition to processing of traditional payment methods like credit/debit/HSA cards and checks. 4. Compliance tools so providers are compliant with federal and state consumer protection laws. FinPay`s mission is to provide a patient financial experience that mirrors the high quality clinical care experienced by most patients. At the core of our programs is a change in conversation at the point-of-care. A conversation that starts with helping the patient understand their financial obligations. A conversation that simplifies the process by giving patients what they want, more options to fit their household budget and more transparency. A conversation that results in facilitating a payment program they can afford, and more importantly, one they have the best chance of actually paying.
Health Plus Management Services, LLC (“Health Plus”) provides the most effective solutions for physicians who wish to outsource their practice`s non-medical functions. Our experienced and knowledgeable employees manage the daily non-medical operations for independently-owned physician practices throughout New York. Through a variety of marketing and advertising initiatives, we also raise awareness of our clients` practices and the field of physical medicine and rehabilitation. We provide our services strictly to physicians who are dedicated to providing high quality care.
Avaxia is a leader in the growing field of gut-targeted therapeutics — orally administered, minimally absorbed drugs that are designed to act locally in the gastrointestinal tract. Avaxia’s lead clinical candidate, AVX-470, is an oral anti-TNF antibody for inflammatory bowel disease. This transformative product offers potentially improved safety and efficacy over existing anti-TNF therapies by focusing immune suppression only where needed in the diseased gut. Avaxia plans to use its gut-targeted antibody platform to develop therapeutics to address many other serious diseases such as type 2 diabetes, celiac disease, GI acute radiation syndrome and oral mucositis.